Colestipol hydrochloride

This classification denotes an anti-lipidemic agent with the molecular formula ((C3H5ClO)mon(C4H13N3)mon)co.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier X7D10K905G, chemically known as copolymer of diethylenetriamine and 1-chloro-2,3-epoxypropane, hydrochloride (with approximately 1 out of 5 amine nitrogens protonated) but more generally known as colestipol hydrochloride, which bears US NIH Compound Identifier 3084661. European Medicines Agency schedules Colestipol hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13441MIG. Most nations, for tariff and trade purposes, schedule colestipol hydrochloride under HS 39140000 and SITC 57597. Colestipol hydrochloride bears US NLM identifiers UMLS ID C0354648 and NCI Concept Code C28938. SMILES: As of Q4 2014, COLESTIPOL HYDROCHLORIDE remains US FDA's Preferred Term for this commodity.